Alan Schwebel - BIO VIEW CEO and Pres

BIOV -- Israel Stock  

ILS 266.70  0.70  0.26%

  CEO
Dr. Alan Schwebel serves as Chief Executive Officer and Director at Bio View Ltd since March 19, 2009. Previously, he served as Vice President of Sales and Marketing at the Company from May 12, 2002 until March 19, 2009. Dr. Schwebel has more than 20 years of experience in senior management positions in Medical Device and Medical Diagnostic Companies. Prior to joining the Company, he served as President of Mennen Medical Ltd., a medical device company
Age: 59  CEO Since 2009  Ph.D    
972 73 227 1025  http://www.bioview.com
Schwebel holds a Doctorate of Science degree in Chemistry from City University of New York and a B.Sc. degree in Chemistry from the City University of New York at Brooklyn College.

Management Efficiency

The company has return on total asset (ROA) of (3.69) % which means that it has lost $3.69 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (6.08) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 2.57M in total debt with debt to equity ratio (D/E) of 11.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BIO VIEW has Current Ratio of 2.1 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 7 records

CEO Since

Amiram GinigerTAYA INVESTMENT CO
2018
Ilan AdmonWILLY FOOD INVSTM
2016
Tim CrankoWILLY FOOD INVSTM
N/A
Kobi LevyWILLY FOOD INVSTM
2011
Iram GraiverWILLY FOOD INVSTM
2015
Michael LuboschitzWILLY FOOD INVSTM
2018
Gil HochboimWILLY FOOD INVSTM
2017

Entity Summary

BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.BIO VIEW (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 12 people.

BIO VIEW Leadership Team

Elad Kfir, Vice President of Marketing
Eliane Markowitz, External Director
Yuval Harari, Co-CEO, Director
Emmanuel Gill, Chairman of the Board
David Kutas, CEO of BioView Inc - USA and President of BioView Inc - USA
Yacha Sutton, Director
Marina Wolfson, CFO
Alan Schwebel, CEO and Pres
Jackie RosenblumGoren, External Director
Inbal Hillel, Vice President - Operations
Lior Shav, Director
Eliyahu AyalonLanciano, External Director
Warren Esanu, Director

Stock Performance Indicators

Current Sentiment - BIOV

BIO VIEW Investor Sentiment

Most of Macroaxis users are currently bullish on BIO VIEW. What is your opinion about investing in BIO VIEW? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

BIO VIEW Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for BIO VIEW and TAYA INVESTMENT CO. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com